Baldwin Investment Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-19,695
Closed -$1.96M 175
2019
Q3
$1.96M Sell
19,695
-490
-2% -$46.6K 0.57% 23
2019
Q2
$1.87M Sell
20,185
-150
-0.7% -$14.2K 0.54% 25
2019
Q1
$1.92M Hold
20,335
0.58% 23
2018
Q4
$1.3M Buy
20,335
+550
+3% +$40.6K 0.41% 34
2018
Q3
$1.77M Sell
19,785
-200
-1% -$17.7K 0.51% 25
2018
Q2
$1.59M Sell
19,985
-450
-2% -$37.4K 0.5% 26
2018
Q1
$1.82M Buy
20,435
+475
+2% +$45.6K 0.65% 15
2017
Q4
$2.08M Buy
19,960
+325
+2% +$36.7K 0.74% 8
2017
Q3
$2.86M Hold
19,635
1.08% 3
2017
Q2
$2.55M Sell
19,635
-500
-2% -$61.3K 1.02% 4
2017
Q1
$2.5M Sell
20,135
-950
-5% -$114K 0.97% 6
2016
Q4
$2.44M Sell
21,085
-400
-2% -$44.5K 0.97% 5
2016
Q3
$2.25M Sell
21,485
-400
-2% -$43.3K 0.96% 6
2016
Q2
$2.16M Sell
21,885
-325
-1% -$33.6K 0.93% 4
2016
Q1
$2.22M Sell
22,210
-1
-0% -$103 0.96% 5
2015
Q4
$2.66M Buy
22,211
+551
+3% +$63.7K 1.2% 3
2015
Q3
$2.34M Sell
21,660
-25
-0.1% -$3.1K 1.03% 5
2015
Q2
$2.51M Sell
21,685
-100
-0.5% -$11.4K 1.04% 3
2015
Q1
$2.51M Sell
21,785
-1,425
-6% -$170K 0.99% 3
2014
Q4
$2.6M Buy
23,210
+150
+0.7% +$15.8K 1.01% 3
2014
Q3
$2.19M Sell
23,060
-250
-1% -$22.6K 0.9% 5
2014
Q2
$2M Buy
23,310
+1,460
+7% +$111K 0.87% 6
2014
Q1
$1.52M Sell
21,850
-1,900
-8% -$150K 0.67% 12
2013
Q4
$2.01M Sell
23,750
-400
-2% -$31.7K 0.9% 4
2013
Q3
$1.86M Sell
24,150
-900
-4% -$63.1K 0.9% 4
2013
Q2
$1.47M Buy
+25,050
New +$1.51M 0.73% 9

Other funds holding CELG

Baldwin Investment Management's CELG Position: Q4 2019 in Review

Baldwin Investment Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 19,695 shares — an estimated $1.96M sold.

Baldwin Investment Management first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $2.86M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Baldwin Investment Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Baldwin Investment Management sold 19,695 Celgene Corp shares in Q4 2019, an estimated $1.96M.
  • Baldwin Investment Management first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Baldwin Investment Management's Celgene Corp position peaked at $2.86M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Baldwin Investment Management's 13F filing for Q4 2019, filed 10 Feb 2020.